Stock Alert for OXiGENE Inc. (OXGN)
OXiGENE (OXGN) is a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases. The Company’s primary focus is the development of product candidates referred to as vascular disrupting agents (VDAs) that selectively disable and destroy abnormal blood vessels that provide solid tumors a means of growth and survival and also are associated with visual impairment in a - Continue Reading »
When will Generex Biotechnology (GNBT) stop falling?
GNBT has been around forever in the pennystock world. It has been touted as the next Nasdaq stock (or a piece of crap that is going to zero) in the time that I have been watching it. It definitely isn’t going to zero, but right now traders and investors are down on GNBT…..for good reason. Generex Biotechnology Corporation (GNBT) is - Continue Reading »




